Australia -
English -
Department of Health (Therapeutic Goods Administration)
rasagiline-teva rasagiline (as mesilate) 1 mg tablet blister pack
teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - rasailine-teva is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
Canada -
English -
Health Canada
azilect tablet
teva canada limited - rasagiline (rasagiline mesylate) - tablet - 0.5mg - rasagiline (rasagiline mesylate) 0.5mg - monoamine oxidase b inhibitors
Canada -
English -
Health Canada
azilect tablet
teva canada limited - rasagiline (rasagiline mesylate) - tablet - 1mg - rasagiline (rasagiline mesylate) 1mg - monoamine oxidase b inhibitors
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
a a h pharmaceuticals ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
hbs healthcare ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
dr reddy's laboratories (uk - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
accord healthcare ltd - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
rivopharm (uk - rasagiline - tablet - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rasagiline 1mg tablets
milpharm ltd - rasagiline - tablet - 1mg
Australia -
English -
Department of Health (Therapeutic Goods Administration)
rasagiline b&b rasagiline (as mesilate) 1 mg tablet blister pack
gm pharma international pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: purified talc; maize starch; citric acid monohydrate; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; pregelatinised maize starch - rasagiline is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.